Ocaliva in Treating Primary Biliary Cholangitis (PBC) Causes Liver Injury: New Liver Injury Warnings[i] and Full Withdrawal[ii]
Dangerous Drugs Ocaliva in Treating Primary Biliary Cholangitis (PBC) Causes Liver Injury: New Liver Injury Warnings[i] and Full Withdrawal[ii] Written by Rafsana Writu What is Primary Biliary Cholangitis? Ocaliva was sold by Intercept Pharmaceuticals for the treatment of primary biliary cholangitis (PBC), an autoimmune View Article December 12, 2025
